Updated Jul 16, 2026 · Last SEC filing 2026-05-22
ProMIS Neurosciences Inc. (PMN) has filed 10 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-22. 2 Form 8-K material event filings were reported by PMN in the last 90 days. InsiderAlpha tracks every PMN SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001374339 |
| Form 4 filings (90d) | 10 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-05-22 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Kirwin Patrick D. | Director | P — Open-market purchase | 4.0K | $11.33 | $45K | SEC | |
| Williams Eugene | Director | P — Open-market purchase | 2.0K | $24.40 | $49K | SEC | |
| Williams Eugene | Director | P — Open-market purchase | 2.0K | $24.00 | $48K | SEC | |
| Williams Eugene | Director | P — Open-market purchase | 1.0K | $21.89 | $22K | SEC | |
| Williams Eugene | Director | P — Open-market purchase | 1.0K | $22.53 | $23K | SEC | |
| Kaplan Johanne | Chief Development Officer | P — Open-market purchase | 1.6K | $15.35 | $25K | SEC | |
| Kirwin Patrick D. | Director | A — Grant or award | 3.0K | $12.13 | $37K | SEC | |
| ABG Management Ltd. | 10% Owner | P — Open-market purchase | 700.7K | $12.13 | $8.50M | SEC | |
| Cashman Neil | Chief Scientific Officer | A — Grant or award | 4.1K | $12.13 | $50K | SEC | |
| Kaplan Johanne | Chief Development Officer | A — Grant or award | 2.1K | $12.13 | $25K | SEC | |
| Warma Neil K | Chief Executive Officer | A — Grant or award | 6.2K | $12.13 | $75K | SEC | |
| Milbury Max A. | Insider | A — Grant or award | 6.6K | $12.13 | $80K | SEC | |
| Milbury Max A. | Insider | P — Open-market purchase | 30.4K | $0.49 | $15K | SEC | |
| Jeremy M. Sclar 2012 Irrevocable Family Trust | 10% Owner | J — Other acquisition / disposition | 697.7K | — | — | SEC | |
| Sclar Jeremy M. | 10% Owner | J — Other acquisition / disposition | 697.7K | — | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for ProMIS Neurosciences Inc. (PMN). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Alex Slanix Paul | 2 | — |
| Mandel-Brehm Josh | 2 | — |
| WYMAN WILLIAM W | 2 | — |
| Shafmaster Madge K. | 2 | — |
| Williams Eugene | 2 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in PMN insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live PMN dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.